当前位置: 首页 > 期刊 > 《中国实用医药》 > 2012年第30期 > 正文
编号:12317933
树突状细胞与细胞因子诱导的杀伤细胞疗法对心脏的影响(2)
http://www.100md.com 2012年10月25日 安东建等
第1页

    参见附件。

     参 考 文 献

    [1] DeVita VT, Rosenberg SA. Two hundred years of cancer research. N Engl J Med, 2012, 366:2207—2214.

    [2] Silvestri P, Di Russo C, Rigattieri S, et al. MiroRNAs and ischemic heart disease: towards a better comprehension of pathogenesis, new diagnostic tools and new therapeutic targets. Recent Pat Cardiovasc Drug Discov, 2009, 4:109—118.

    [3] Yue P, Zhang Y, Du Z, et al. Ischemia impairs the association between connexin 43 and M3 subtype of acetylcholine muscarinic receptor (M3—mAChR) in ventricular myocytes. Cell Physiol Biochem, 2006, 17(34):129—136.

    [4] Gong DM, Shan HL, Zhou YH, et al. the ion targets of arrhythmias induced by ouabain and aconitine in guinea pig and rat ventricular myocytes. Acta Pharm Sin, 2004, 39(5):328—332.

    [5] Schmidt—Wolf IG, Lef terova P, Mehta BA, et al. Phenotypic characterization and identification of effect or cells involved in tumor cell recognition of cytokine—induced killer cells. Exp Hematol, 1993, 21(13): 1673—1679.

    [6] Jiang J,Xu N,Wu C,et al.Treatment of advanced gastric cancer by chemotherapy combined with autologous cytokine—induced killer cells.Anticancer Res,2006,26(3B):2237—2242.

    [7] Hongeng S, Petvises S, Worapongpaiboon S, et al. Generation of CD3+ CD56+ cytokine—induced killer cells and their in vitro cytotoxicity against pediatric cancer cells. Int J Hematol,2003,77(2):175—179.

    [8] Erhadt M, Schmidt—Wolf I G, Sievers E, et al. Anti—tumoral capabilities of effector cells after IFN—alpha or CpG—motif treatment of cocultured dendritic cells.Arch Immunol Ther Exp(Warsz),2006,54(6):403—409.

    [9] Kleindienst P,Wiethe C,Lutz MB,et al.Simultaneous induction of CD4 T cell tolerance and CD8 T cell immunity by semimature dendritic cells.J lmmunol ......

您现在查看是摘要介绍页,详见PDF附件(2741kb)